SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-24-000152
Filing Date
2024-05-17
Accepted
2024-05-17 16:24:43
Documents
1
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1715977463.html 4  
1 FORM 4 wk-form4_1715977463.xml 4 3970
  Complete submission text file 0000875320-24-000152.txt   5404
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 24960133